Inventor
ULRICH HERSEL
Inventor
DE
Overview
Patents· 13 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes36%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations36%
Y02ATechnologies for adaptation to climate change14%
C07KPeptides11%
C08JWorking-up3%
PatentTitleYear
12,544,428Controlled-release CNP agonists with reduced side-effects202612,377,133Dry pharmaceutical formulations of CNP conjugates202512,274,737PEGylated recombinant human growth hormone compounds202512,239,689Controlled-release CNP agonists with low initial NPR-B activity202512,156,917CNP prodrugs with carrier attachment at the ring moiety202412,083,182Controlled-release CNP agonists with increased NEP stability202411,559,482Biodegradable polyethylene glycol based water-insoluble hydrogels202311,413,351CNP prodrugs with carrier attachment at the ring moiety202211,389,511Controlled-release CNP agonists with reduced side-effects202211,389,510Controlled-release CNP agonists with low initial NPR-B activity202211,311,604Controlled-release CNP agonists with low NPR-C binding202211,224,661Controlled-release CNP agonists with increased NEP stability202211,154,593CNP prodrugs with large carrier moieties2021Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2021–2026Patents assigned to ASCENDIS PHARMA GROWTH DISORDERS AS (11)· patent assignee history
2021–2026Based in DE· patent location history
2023Patents assigned to ASCENDIS PHARMA AS (1)· patent assignee history
2023Patents assigned to HERSEL ULRICH (1)· patent assignee history
2023Patents assigned to KRUSCH MATHIAS (1)· patent assignee history
2025Patents assigned to ASCENDIS PHARMA ENDOCRINOLOGY DIV A/S (1)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| ASCENDIS PHARMA GROWTH DISORDERS AS | 11 | 2021–2026 |
| ASCENDIS PHARMA AS | 1 | 2023 |
| ASCENDIS PHARMA ENDOCRINOLOGY DIV A/S | 1 | 2025 |
| HERSEL ULRICHself | 1 | 2023 |
| KRUSCH MATHIAS | 1 | 2023 |
Locations
| Location | Patents | Span |
|---|---|---|
| DE | 13 | 2021–2026 |